Latest News for: Riga office

Edit

US FDA panel votes against Spectrum's lung cancer drug

Gulf Daily News 23 Sep 2022
"Clearly there's a clinical unmet need for the drug ... 24 ... Spectrum Chief Executive Officer Tom Riga, in a statement, expressed disappointment at the meeting's outcome and said the company plans to carefully evaluate its options for this program as it nears the FDA's decision date ... .
Edit

Spectrum Pharmaceuticals Announces Debt Financing Agreement with SLR Capital Partners with $30 Million Funded at Closing

Eagle-Tribune 23 Sep 2022
BOSTON--(BUSINESS WIRE)--Sep 23, 2022-- ... (NasdaqGS ... This capital commitment immediately strengthens our balance sheet and is anticipated to provide the additional resources necessary for a successful launch of ROLVEDON,” said Tom Riga, President and Chief Executive Officer of Spectrum Pharmaceuticals ... CONTACT. Tom Riga. Chief Executive Officer ... KEYWORD ... .
Edit

Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting

The Facts 22 Sep 2022
BOSTON--(BUSINESS WIRE)--Sep 22, 2022-- ... “We are disappointed by the outcome of the ODAC meeting, as patients with NSCLC HER2 exon 20 insertion mutations are in need of additional effective and safe therapies,” stated Tom Riga, President and Chief Executive Officer of Spectrum Pharmaceuticals ... Spectrum Contacts.Tom Riga. Chief Executive Officer ... PUB.
Edit

Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection

Pharmiweb 10 Sep 2022
(NasdaqGS ... “ROLVEDON’s approval marks Spectrum’s transformation to a commercial-stage company with the opportunity to compete in a $2 billion dollar market, and offers a unique value proposition,” said Tom Riga, President and Chief Executive Officer of Spectrum Pharmaceuticals ... About ROLVEDON™ ... Indications and Usage ... Tom Riga. Chief Executive Officer ... .
Edit

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 ...

The Facts 10 Sep 2022
BOSTON--(BUSINESS WIRE)--Sep 10, 2022--. Spectrum Pharmaceuticals, Inc. (NasdaqGS. SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced data from a poster presentation titled ... About Poziotinib ... About Spectrum Pharmaceuticals, Inc ... © 2022 Spectrum Pharmaceuticals, Inc ... Tom Riga. Chief Executive Officer ... PUB.
Edit

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778—P780dup HER2 ...

The Galveston Daily News 10 Sep 2022
BOSTON--(BUSINESS WIRE)--Sep 10, 2022--. Spectrum Pharmaceuticals, Inc. (NasdaqGS. SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced data from a poster presentation titled ... About Poziotinib ... About Spectrum Pharmaceuticals, Inc ... © 2022 Spectrum Pharmaceuticals, Inc ... Tom Riga. Chief Executive Officer ... PUB.
Edit

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022

Pharmiweb 10 Sep 2022
BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS ... “The G778 mutation is one of the frequent HER2 exon 20 insertion mutations and patients with these tumors have a poor prognosis,” said Francois Lebel, M.D., Chief Medical Officer of Spectrum Pharmaceuticals ... Results for Poziotinib in this Patient Group ... Tom Riga. Chief Executive Officer.
Edit

Spectrum Pharmaceuticals Announces Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at the Upcoming ESMO Congress 2022

Pharmiweb 05 Sep 2022
BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS. SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation titled. High Activity of Poziotinib in G778_P780dup HER2 Exon 20 Insertion Mutations in Non-Small Lung Cancer (NSCLC) ... Title ... Location ... Tom Riga. Chief Executive Officer ... .
Edit

Spectrum Pharmaceuticals Announces Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 ...

The Facts 05 Sep 2022
BOSTON--(BUSINESS WIRE)--Sep 5, 2022--. Spectrum Pharmaceuticals (NasdaqGS. SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation titled. High Activity of Poziotinib in G778_P780dup HER2 Exon 20 Insertion Mutations in Non-Small Lung Cancer (NSCLC) ... ... Tom Riga. Chief Executive Officer.
Edit

Spectrum Pharmaceuticals Announces Poster Presentation for Poziotinib in NSCLC Patients with G778—P780dup HER2 Exon 20 ...

The Galveston Daily News 05 Sep 2022
BOSTON--(BUSINESS WIRE)--Sep 5, 2022--. Spectrum Pharmaceuticals (NasdaqGS. SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation titled. High Activity of Poziotinib in G778—P780dup HER2 Exon 20 Insertion Mutations in Non-Small Lung Cancer (NSCLC) ... ... Tom Riga. Chief Executive Officer.
Edit

Przezdziecki fights in two more wars

The Am-Pol Eagle 29 Aug 2022
As the commanding officer of the Polish 12th Infantry Division, I fought in the Polish-Bolshevik War. After the Peace of Riga I remained in service at various staff posts. In 1926 I became the commanding officer of the Polish 21st Mountain Infantry Division and the following year, I was promoted to the rank of Brigadier General.
Edit

KKE: “Hands off the anti-fascist monuments of Europe”

Greek City Times 25 Aug 2022
The Red Army’s antifascist Victory cannot be erased! Hands off the anti-fascist monuments of Europe,” points out a statement of the Press Office of the CC of the Communist Party of Greece (KKE) concerning the dismantling of the Soviet monument in Riga, Latvia on 23 August.
Edit

Recounts in state representative, Lenawee County Commission primaries start Thursday

The Daily Telegram 24 Aug 2022
The District 7 county commission seat covers Blissfield, Deerfield, Ogden, Palmyra, Ridgeway and Riga townships. There was a difference of just four votes in that race with commissioner Jim Goetz of Ogden Township at 947 votes and challenger Kevon Martis of Riga at 951 votes.
Edit

Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

The Facts 11 Aug 2022
BOSTON--(BUSINESS WIRE)--Aug 11, 2022--. Spectrum Pharmaceuticals, Inc. (NasdaqGS ... With this hurdle behind us, we have turned our focus to our potential approval and commercialization,” said Tom Riga, President and Chief Executive Officer of Spectrum Pharmaceuticals ... Pipeline Updates ... ET ... Pacific ... robert.uhl@westwicke.comTom Riga. Chief Executive Officer.
Edit

Fatal crash in Whiteford Township claims life of 24-year-old Riga woman

The Daily Telegram 04 Aug 2022
A 24-year-old Riga woman died early Wednesday morning from injuries sustained when the vehicle she was driving in Whiteford Township reportedly left the roadway at high speed for unknown reasons ... Wednesday on South County Line Highway, south of Ottawa Lake Road, according to a press release issued by the Monroe County Sheriff's Office.

Most Viewed

Abdul Salam Hanafi, a deputy prime minister in the Taliban's interim government, left, speaks with acting Foreign Minister of Afghanistan, Taliban official Amir Khan Muttaqi during talks involving Afghan representatives in Moscow, Russia, Wednesday, Oct. 20, 2021.
AP / Alexander Zemlianichenko, Pool
File - Russia's President Vladimir Putin and Russian Defense Minister Sergei Shoigu, right, attend the opening of the Army 2022 International Military and Technical Forum in the Patriot Park outside Moscow, Russia, Aug. 15, 2022.
AP / Sputnik, Kremlin Pool Photo via AP, File
×